Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of integrated biological effectiveness of eye plaques with <sup>125</sup>I and <sup>103</sup>Pd photon sources using equivalent uniform RBE-weighted dose.

Medical physics·2025
Same author

A hybrid IGRT workflow using SGRT and CBCT for prostate SBRT: Feasibility, efficiency, and safety.

Journal of applied clinical medical physics·2025
Same author

Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotyping.

Urologic oncology·2025
Same author

The expanding role of radiation oncology across the prostate cancer continuum.

Abdominal radiology (New York)·2024
Same author

Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older.

Frontiers in oncology·2024
Same author

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma.

Cancers·2023

Related Experiment Video

Updated: Feb 17, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

988

Fighting Resilient Cancers with Iron.

Jonathan J Chen1, Lorenzo Galluzzi2

  • 1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.

Trends in Cell Biology
|December 11, 2017
PubMed
Summary
This summary is machine-generated.

Cancer cells can become more vulnerable to ferroptosis when they transition to a mesenchymal state during tumor progression. This vulnerability may offer new therapeutic strategies for treating residual cancer disease.

Keywords:
epithelial-to-mesenchymal transitionglutathionelipid peroxidationpolyunsaturated fatty acidsregulated cell deathstatins

More Related Videos

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.9K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.0K

Related Experiment Videos

Last Updated: Feb 17, 2026

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

988
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

3.9K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.0K

Area of Science:

  • Oncology
  • Cancer Biology
  • Cellular Differentiation

Background:

  • Tumor progression and treatment resistance are linked to malignant cell dedifferentiation.
  • Malignant cell polarization towards a mesenchymal state is a hallmark of advanced cancers.
  • This cellular plasticity contributes to therapeutic challenges in oncology.

Purpose of the Study:

  • To investigate the link between mesenchymal transition and ferroptosis sensitivity in cancer.
  • To explore the therapeutic potential of targeting ferroptosis in poorly differentiated tumors.
  • To identify novel strategies for overcoming treatment resistance in residual cancer disease.

Main Methods:

  • Analysis of cellular differentiation markers.
  • Assessment of ferroptosis induction under various conditions.
  • In vitro and in vivo cancer models were utilized.

Main Results:

  • Malignant cells undergoing mesenchymal transition exhibit increased susceptibility to ferroptosis.
  • This vulnerability is linked to specific metabolic alterations associated with dedifferentiation.
  • Targeting ferroptosis pathways showed efficacy in preclinical models of residual disease.

Conclusions:

  • The mesenchymal state in cancer cells creates a window of vulnerability to ferroptosis.
  • Exploiting this vulnerability presents a promising therapeutic avenue for difficult-to-treat cancers.
  • Targeting ferroptosis could be key in managing residual disease and preventing relapse.